Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Chiara Pierdomenico. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chiara Pierdomenico or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Leadership and disruptive innovation in biotech and mental health care: A conversation with Kabir Nath, CEO of Compass Pathways

35:26
 
Share
 

Manage episode 432656883 series 2975696
Content provided by Chiara Pierdomenico. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chiara Pierdomenico or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this next episode of The Heidrick & Struggles Leadership Podcast, Heidrick & Struggles’ Charlie Moore speaks to Kabir Nath, the CEO of Compass Pathways. Compass Pathways is a company dedicated to studying investigational psilocybin treatment in treatment-resistant depression, post-traumatic stress disorder, and anorexia. Kabir Nath, whose career has spanned approximately 30 years in the biopharmaceutical and medical device industry, was previously the senior managing director of the global pharmaceutical company Otsuka Pharmaceuticals. In this conversation, Nath shares what attracted him to the biotech space and what it’s like to take over the helm of a company from founders, and how he’s collaborated with them during the transition. He also discusses his perspective on healthcare accessibility, evolving an organizational culture as the business grows, what new skill sets or capabilities he is looking for in talent, and how he manages investor relations. Finally, he shares how he is preparing the leadership team for the organization’s continued transformation over the next few years.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

205 episodes

Artwork
iconShare
 
Manage episode 432656883 series 2975696
Content provided by Chiara Pierdomenico. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chiara Pierdomenico or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this next episode of The Heidrick & Struggles Leadership Podcast, Heidrick & Struggles’ Charlie Moore speaks to Kabir Nath, the CEO of Compass Pathways. Compass Pathways is a company dedicated to studying investigational psilocybin treatment in treatment-resistant depression, post-traumatic stress disorder, and anorexia. Kabir Nath, whose career has spanned approximately 30 years in the biopharmaceutical and medical device industry, was previously the senior managing director of the global pharmaceutical company Otsuka Pharmaceuticals. In this conversation, Nath shares what attracted him to the biotech space and what it’s like to take over the helm of a company from founders, and how he’s collaborated with them during the transition. He also discusses his perspective on healthcare accessibility, evolving an organizational culture as the business grows, what new skill sets or capabilities he is looking for in talent, and how he manages investor relations. Finally, he shares how he is preparing the leadership team for the organization’s continued transformation over the next few years.

Hosted on Acast. See acast.com/privacy for more information.

  continue reading

205 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play